MOUMITA KUNDU | Neuro-oncology | Best Researcher Award

Posted on by ScienceFather

Dr. MOUMITA KUNDU | Neuro-oncology | Best Researcher Award

Associate Professor at  Brainware University ,India

Dr. Moumita Kundu is an Associate Professor and Executive Research Member at Brainware University, Barasat, Kolkata, West Bengal. She is a dedicated researcher with significant expertise in cancer biology, cancer therapeutics, and smart & targeted drug delivery systems. Her doctoral research focused on glioma therapeutics, investigating the potential of magnolol, a natural anti-glioma agent from magnolia. With glioma being an incurable disease and a high mortality rate due to limited treatment options, her work aims to identify compounds with high anti-glioma activity that can penetrate the blood-brain barrier while minimizing toxicity.

 

Profile:

Education

Dr. Kundu earned her Ph.D. from IIT Kharagpur in 2022. She holds an M.Pharm degree from Jadavpur University, where she graduated in 2015 with a CGPA of 9.00, ranking third in her class. She completed her B.Pharm at Jadavpur University in 2013 with a CGPA of 8.68, securing first place in the university. Her early education includes completing her 10+2 from W.B.C.H.S.E. in 2009 with 81.4%, and her 10th grade from W.B.B.S.E. in 2007, achieving 89%.

 

Professional Experiences 

Dr. Kundu has held various positions in academia and the pharmaceutical industry. She worked as a Research Associate at KIIT Deemed University from February 2023 to May 2023. Previously, she served as a Research Biologist in the In-Vitro Department at Curadev Pharma Pvt. Ltd. from August 2015 to October 2016. These experiences honed her skills in bioanalytical method validation, molecular screening of anti-cancer agents, and ADME assay optimization.

 

Professional skills 

Her technical expertise includes standardizing and troubleshooting in-vitro ADME assays, developing methods for purity determination of unknown compounds using HPLC and LCMS, and analyzing pharmacokinetic study samples. Additionally, she has vast experience in molecular pathway screening of anti-cancer agents, in-vivo animal experiments, and advanced techniques like Western Blotting, Real-Time PCR, immunofluorescence, and immunohistochemistry.

 

Awards and Honors

Dr. Kundu has made significant contributions to her field, reflected in her impressive h-index of 9. She has published 17 journal articles, authored 1 book, contributed to 2 book chapters, and presented at 1 major conference.

 

Memberships and Teaching Experience

While specific details of her memberships are not listed, Dr. Kundu’s roles as Associate Professor at Brainware University and past teaching experience at KIIT Deemed University underline her active engagement in academic leadership and mentorship in the field of pharmaceutical sciences.

Research focus 

Her primary research focuses on developing and optimizing methods to improve the effectiveness of anti-cancer therapies, particularly those related to glioma. She is actively involved in molecular pathway analysis, pharmacokinetics, and targeted drug delivery systems to combat cancer.

 

Publication Top Notes

  • Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer
    Year: 2024
    Journal: Molecular Cancer
  • Dual perspective on autophagy in glioma: Detangling the dichotomous mechanisms of signaling pathways for therapeutic insights
    Year: 2024
    Journal: Biochimica et Biophysica Acta – Reviews on Cancer
  • Molecular pathways in breast cancer chemoresistance
    Year: 2024
    Journal: Handbook of Oncobiology: From Basic to Clinical Sciences
  • Acceleration of wound healing by PVA-PEG-MgO nanocomposite hydrogel with human epidermal growth factor
    Year: 2023
    Journal: Materials Today Communications
  • Magnolol and Temozolomide exhibit a synergistic anti-glioma activity through MGMT inhibition
    Year: 2023
    Journal: Biochimica et Biophysica Acta – Molecular Basis of Disease
  • A novel computational predictive biological approach distinguishes Integrin β1 as a salient biomarker for breast cancer chemoresistance
    Year: 2023
    Journal: Biochimica et Biophysica Acta – Molecular Basis of Disease
  • Therapeutic implications of cancer stem cells in prostate cancer
    Year: 2023
    Journal: Cancer Biology and Medicine
  • Magnolol induces cytotoxic autophagy in glioma by inhibiting PI3K/AKT/mTOR signaling
    Year: 2023
    Journal: Experimental Cell Research
  • Glycopolymer decorated pH-dependent ratiometric fluorescent probe based on Förster Resonance Energy Transfer for the detection of cancer cells
    Year: 2023
    Journal: Macromolecular Rapid Communications